ECOWAS Essential Medicines & Vaccines
WA-MRH
Lang
English
French
Portuguese
ECOWAS Essential Medicines & Vaccines
WA-MRH
About Us
Overview - History & Mission
What We Do
Benefits
Success Stories
WA-MRH
Partners
Member Login
Communities of Practice
Member States
Benin
Burkina Faso
Cabo Verde
Cote d'Ivoire
The Gambia
Ghana
Guinea
Guinea-Bissau
Liberia
Mali
Niger
Nigeria
Senegal
Sierra Leone
Togo
ECOWAS
Regional Basket
Events & News
News media
Upcoming Events
Photo Gallery
Video Gallery
Document Center
Guidelines
SOPs
Manuals
Templates
Library
Publications
|
Lang
English
French
Portuguese
We use cookies, just to track visits to our website, we store no personal details.
Learn More
Accept
WAHO Guideline on Good Pharmacovigilance Practice
Author:
WAHO
Category:
Clinical Trials, Pharmacovigilance and Medicines Safety
Language:
English
Date Updated:
8/10/2020 8:12:11 AM
Description
This Guideline is hereby made by WAHO with references from Good Pharmacovigilance guidelines Nigeria, FDA Ghana, Pharmacy Board of Sierra Leone, MCC South African, ICH and WHO to define the general norms and scientific principles and to set applicable standards for the conduct, performance and control of pharmacovigilance activities in West Africa.
Abstract
underlying objectives of this guideline are to: • harmonize the requirement for reporting adverse reactions in humans arising from the use of Authorized medicinal products within or outside the terms of marketing Authorization; • promote the safe and effective use of medicine, in particular through providing timely information about the safety of medicine to patients, healthcare professionals, marketing Authorization holder and the public. • contribute to the protection of patients’ and public health.
Download PDF
Back To List
Feedback
×
Submit a feedback
Contact Email
Feedback Title
Feedback
Submit
